WORK Medical Technology (WOK) Cash & Equivalents (2023 - 2025)

WORK Medical Technology has reported Cash & Equivalents for 3 years, with the latest figure at $4.1 million in Q3 2025.

• For the quarter ending Q3 2025, Cash & Equivalents fell 37.65% year-over-year to $4.1 million; the trailing twelve-month figure through Sep 2025 stood at $4.1 million (down 37.65% YoY), and the FY2025 full-year result was $4.1 million, down 37.65% from the prior year.
• Cash & Equivalents for Q3 2025 stood at $4.1 million, down from $6.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $6.6 million in Q3 2024, with the low at $1.6 million in Q3 2023.
• Historically, Cash & Equivalents has averaged $4.7 million across 3 years, with a median of $5.3 million in 2024.
• Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 310.85% — and 2025, when it slumped 37.65%.
• WORK Medical Technology's Cash & Equivalents stood at $1.6 million in 2023, then jumped by 310.85% to $6.6 million in 2024, then slumped by 37.65% to $4.1 million in 2025.
• The last three Cash & Equivalents figures came in at $4.1 million (Q3 2025), $6.6 million (Q1 2025), and $6.6 million (Q3 2024), per Business Quant data.